During the past decade, Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "CENTOGENE GmbH Rostock" with 2 trials sponsored, "Jena University Hospital" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "D-Pharm Ltd." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" #1 collaborator was "Shire Human Genetic Therapies, Inc." with 2 trials as a collaborator, "Center for Sepsis Control and Care, Germany" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "Instituto Grifols, S.A." with 1 trials as a collaborator and "SepNet - Critical Care Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" are "Multiple Sclerosis" (3 trials), "Cerebrovascular Accident" (2 trials), "Autoimmune Encephalitis" (1 trials), "Brain Ischemia" (1 trials) and "Cerebrovascular Disorders" (1 trials). Many other conditions were trialed in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" are "Drug" (8 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Placebo" (3 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials) and "No intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie". 1 are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Leipzig - Klinik und Poliklinik für Neurologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".